期刊文献+

牛蒡子苷自微乳在体肠吸收分析方法学研究 被引量:1

Analytical methodology on in situ rat intestine absorption of arctiin SMEDDS
原文传递
导出
摘要 目的建立HPLC法测定牛蒡子苷自微乳中牛蒡子苷含量并考察牛蒡子苷自微乳在大鼠小肠吸收情况。方法采用自微乳化释药系统(SMEDDS)技术制备牛蒡子苷自微乳,并运用大鼠在体灌流的方法建立牛蒡子苷大鼠肠吸收模型,以流动相乙腈-水(35:65),流速1mL/min,检测波长280nm为色谱条件,测定自微乳中牛蒡子苷含量及肠循环液中牛蒡子苷、苷元含量,并考察药物的吸收。结果牛蒡子苷含量测定方法在2—200μg/mL浓度范围内,苷元含量测定方法在1~100ng/mL浓度范围内,均具有良好线性,回收率均在95%~105%范围内,日内及日间RSD均小于5%。测得牛蒡子苷自微乳载药量为(40.090±0.001)mg/g;在体肠吸收结果表明在10~50μg/mL范围内,药物单位时间吸收百分率小于25%;牛蒡子苷自微乳在小肠有一定的吸收,但在30min后开始水解为牛蒡子苷元。结论所建HPLC法专属性强,准确度及精密度能够满足牛蒡子苷自微乳以及在体肠吸收液中牛蒡子苷、苷元含量的测定。 Object ve To establish an HPLC method for determination of arctiin in self-microemulsify- ing drug delivery system (SMEDDS) and studying its absorption in rat intestines. Methods An in situ recirculation model was established to study the absorption of arctiin SMEDDS in rat intestines. The contents of arctiin and arctigenin and drug absorption were determined by HPLC, with mobile phase of acetonitrile-water (35: 65), flow rate 1 mL/min, and detection wavelength 248 nm. Results The method showed good linearity in arctiin concentration range of 2 - 200 μg/mL and arctigenin concentration range of 1 - 100 μg/mL, with recovery rate 95% to 105% and inter-day and intra-day RSD less than 5%. The content of arctiin in microe- mulsion was (40.090 ±0.001 ) mg/g. In the concentration range from 10 to 50 μg/mL, arctiin absorption rate was less than 25%. The arctiin SMEDDS had some absorption in rat intestines but started to hydrolyze and pro- duce arctigenin after 30 min. Conclusion The HPLC method with good specificity, accuracy and precision is qualified for determination of arctiin and arctigenin from SMEDDS and intestinal fluids.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2013年第24期2681-2685,共5页 Journal of Third Military Medical University
基金 重庆市卫生局中医药科技项目(2012-2-25) 科技型中小企业技术创新基金(HC26215113529)~~
关键词 HPLC 牛蒡子苷自微乳 在体肠吸收 含量测定 HPLC arctiin SMEDDS in situ perfusion content determination
  • 相关文献

参考文献9

  • 1王潞,赵烽,刘珂.牛蒡子苷及牛蒡子苷元的药理作用研究进展[J].中草药,2008,39(3):467-470. 被引量:112
  • 2卢来春,张蓉,周世文,蒋学文.AB-8型树脂对牛蒡苷吸附分离性能的研究[J].第三军医大学学报,2007,29(5):439-441. 被引量:6
  • 3Kyatanwar A U, Jadhav K R, Kadam V J. Self micro-emulsifying drug- delivery system (SMEDDS) : Review [J]. J Pharm Res, 2010, 3 (1):75-83.
  • 4江兴龙,贾运涛,张良珂,田睿,滕永真.星点设计-效应面法优化葛根素自微乳化释药系统[J].第三军医大学学报,2012,34(14):1414-1417. 被引量:3
  • 5Porter C J, Trevaskis N L, Charman W N. Lipids and lipid-based for- mulations: optimizing the oral delivery of lipophilic drugs[ J]. Nat RevDrug Discov, 2007, 6 (3) : 231 - 248.
  • 6Gursoy R N, Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilie drugs [ J ]. Biomed Pharmaeother, 2004, 58(3) : 173 - 182.
  • 7李沉纹,罗明和,李卓恒,于彩平,管海燕,卢来春.牛蒡子苷大鼠在体肠吸收动力学研究[J].中草药,2013,44(6):727-730. 被引量:16
  • 8Xie L 14, Ahn E M, Akao T, et al. Transformation of arctiin to estro- genic and antiestrogenic substances by human intestinal bacteria [ J ]. Chem Pharm Bull (Tokyo) , 2003, 51 (4) : 378 -384.
  • 9Wang W, Pan Q, Han X Y, et al. Simultaneous determination of arcti- in and its metabolites in rat urine and feces by HPLC [ J ]. Fitoterapia, 2013, 86:6-12.

二级参考文献46

  • 1王海颖,陈以平.牛蒡子及其提取物对大鼠肾皮质糖基化终产物的影响[J].上海中医药大学学报,2004,18(3):48-51. 被引量:9
  • 2徐朝晖,李婷,邓毅,刘建文,贾伟.牛蒡子提取物的降血糖作用[J].中草药,2005,36(7):1043-1045. 被引量:24
  • 3杨子峰,刘妮,黄碧松,王艳芳,胡英杰,朱宇同.牛蒡子甙元体内抗甲1型流感病毒作用的研究[J].中药材,2005,28(11):1012-1014. 被引量:48
  • 4江涛涛,欧阳臻,缪亚东,张晓峰.大孔树脂吸附纯化何首乌中二苯乙烯苷的研究[J].中国中药杂志,2006,31(8):646-649. 被引量:17
  • 5郑一敏,蔡绍皙,胥秀英,傅善权.牛蒡子苷代谢动力学与分布研究(英文)[J].中国现代应用药学,2006,23(4):265-267. 被引量:6
  • 6Chae S H, Kim P S, Cho J Y, et al. Isolation and identification of inhibitory compounds on TNF-α production from Magnollae fargesii [J]. Arch Pharm Res, 1998, 21 (1): 67-69.
  • 7Cho J Y, Kim A R, Yoo E S, et al. Immunomodulatory effect of arctigenin, a lignan compound on tumor necrosis factor-α and nitric oxide production, and lymphocyte proliferation [J]. J Pharm Pharmacol, 1999, 51 (11): 1267-1273.
  • 8Cho M K, Park J W, Jang Y P, et al. Lipopolysaccharideinducible nitric oxide synthase expression by dibenzylbutyrolactone lignans through inhibition of I-κBα phosphorylation and of p65 nuclear translocation in macrophages [J]. Int Immunopharmacol, 2002, 67 (6) : 1738-1745.
  • 9Cho M K, Jiang Y P, Kim Y C, et al. Arctigenin, a phenylpropanoid dibenzylbutyrolactone lignan, inhibits MAP kinases and AP-1 activation via potent MKK inhibition: the role in TNF-alpha inhibition [J]. Int Immunopharmacol, 2004, 4(10-11): 1419-1429.
  • 10Umehara K, Nakamura M, Miyase T, et al. Studies on differentiation inducers VI. Lignan derivatives from Arctium fructus (Ⅱ) [J]. Chem Pharm Bull, 1996, 44(12): 2300-2304.

共引文献133

同被引文献3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部